Efficacy and Safety of Sericin and Chitosan Cream for Preventing and Limiting the Progressive of Pressure Sore

Efficacy and Safety of Sericin and Chitosan Cream for Preventing and Limiting the Progressive of Pressure Sore

To evaluate efficacy and safety of sericin and chitosan cream for preventing and limiting the progressive of pressure sore in 20 patients

Inclusion Criteria:

• Age more than 18 years old
• 2-digit Stirling Pressure Sore Severity Scale less than or equal to 2.4
• No chitosan, sericin, and dimethicone allergy
• Without skin diseases
• Without Autoimmune diseases
• Willingness to participate

Exclusion Criteria:

• Have uncontrolled diseases
• Have complication or adverse effects during the time of participation
• Cannot follow protocol
• Pregnancy or lactation
• Participate in other study